Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as an Elite provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.

Jennifer Thorne, M.D., Ph.D., is the Cross Family Professor of Ophthalmology at the Wilmer Eye Institute, where she is also chief of the Division of Ocular Immunology. Dr. Thorne holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. An internationally recognized ophthalmologist, Dr. Thorne is an expert in the evaluation and management of patients with uveitis and other related immune-mediated disorders. Dr. Thorne also directs the Mucous Membrane Pemphigoid clinic, a multi-disciplinary specialty clinic designed to evaluate and treat patients with conjunctival diseases. Dr. Thorne's research interests include white dot syndromes including birdshot chorioretinitis, multifocal choroiditis and punctate inner choroiditis. She also studies juvenile idiopathic arthritis-related uveitis and treatment outcomes of immunosuppressive drug therapy. Dr. Thorne received her M.D. degree from the University of Virginia and completed her ophthalmology residency at the University of Pennsylvania's Scheie Eye Institute. She completed her uveitis fellowship at Wilmer and completed her Ph.D. in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Thorne is rated as a Distinguished provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, Cataract Removal, and Vitrectomy.

Bryn M. Burkholder, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute and the Antoinette R. Schifanelli Rising Professor of Ophthalmology, specializing in ocular inflammatory and infectious diseases, cataract surgery and comprehensive ophthalmology. Dr. Burkholder earned her bachelor's degree from Duke University, where she majored in biology, and received her medical degree from the University of Pennsylvania. After completing an internship at the Albert Einstein Medical Center in Philadelphia, she moved to Baltimore for her residency in ophthalmology at the Wilmer Eye Institute. Dr. Burkholder remained at Wilmer for her fellowship training in uveitis before joining the faculty in July 2012. Dr. Burkholder is rated as a Distinguished provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Uveitis, Scleritis, Neuroretinitis, Episcleritis, and Cataract Removal.

Douglas A. Jabs, M.D., M.B.A. is an internationally-recognized expert in the evaluation and management of patients with uveitis and related immune-mediated ocular disorders, particularly on the use of immunosuppression to treat severe ocular inflammatory diseases. Founder of the Division of Ocular Immunology and Uveitis at Wilmer, he now is the Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins University Bloomberg School of Public Health. Dr. Jabs is rated as a Distinguished provider by MediFind in the treatment of Scleritis. His top areas of expertise are Uveitis, CMV Retinitis, Scleritis, Cataract Removal, and Trabeculectomy.

"Dr. Shah is an AUPO-fellowship trained ophthalmologist specializing in diseases of the retina, macula, and vitreous. A Pennsylvania native, Dr. Shah attended college at West Chester University of Pennsylvania. He later earned his medical degree at Drexel University College of Medicine and remained there to pursue his residency in Ophthalmology where he was also honored to serve as Chief Resident. Dr. Shah then pursued his fellowship training in vitreoretinal surgery at the Associated Retina Consultants in Phoenix, Arizona. Dr. Shah has been privileged to author or co-author over 40 book chapters and topics as well as publish scientific articles in peer-reviewed journals. He has been invited to lecture both physicians and students on current clinical issues. As a resident, he received multiple honors including Intern of the Year, Resident of the Year, and the Golden Apple for Teaching by the College of Medicine. He was even bestowed with Hahnemann University Hospital's highest award for training physicians – ""Excellence in Clinical Practice for a Fellow, Resident, or Intern."" Dr. Shah enjoys all aspects of retinal disease, but has particular interests in the management of acute, subacute, and chronic retinal disorders including age-related macular degeneration, diabetic retinopathy, and complex retinal detachments. Dr. Shah is a member of the American Society of Retinal Specialists and the American Academy of Ophthalmology.". Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Orbital Cellulitis, Hyphema, Kallikrein Hypertension, and Optic Atrophy Type 1.

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as an Experienced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Everardo Hernandez-Quintela, M.D., M.Sc., F.A.C.S. is an accomplished cataract and cornea surgeon at the Wilmer Eye Institute’s locations in Baltimore and Lutherville, Maryland. He specializes in both refractive surgery (LASIK and PRK) and corneal transplant. Dr. Hernández-Quintela is the medical director for Wilmer's Patient Access Center for the Eye (PACE). Prior to joining Johns Hopkins Medicine, Dr. Hernandez Quintela was a professor of ophthalmology at the Universidad Nacional Autónoma de México where he led the course on research methodology in ophthalmology and the advanced course on cornea and refractive surgery. He is the founder of the international chapter of the Association of Research in Vision and Ophthalmology (ARVO) in Mexico, known as Colegio Nacional de Investigación en Ciencias Visuales (MARVO). Dr. Hernández-Quintela is a peer review editorial member of the Journal of the American Academy of Ophthalmology and the International Journal of Ophthalmology among other prestigious journals. He held a clinical academic position as head of cornea and refractive surgery services, and head of research at the Asociación para Evitar la Ceguera en México Hospital in Mexico City, which is one of the largest eye hospitals in Latin America. Dr. Hernández-Quintela began his career at Universidad La Salle and Universidad Nacional Autonoma de Mexico in Mexico City. He performed his residency training at the Asociación para Evitar la Ceguera en México Hospital, in Mexico City, and completed his fellowships at the Massachusetts Eye and Ear Infirmary at Harvard Medical School in the United States with professor Dimitri Azar, and at the Hôtel Dieu Hospital, at Université Paris in France with Professor J.M. Legeais and Prof. Yves Pouliquen.Dr. Hernández-Quintela holds a Master in Science from the Universidad Nacional Autónoma de México, School of Medicine. Dr. Hernandez is rated as an Experienced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Cataract, Optic Nerve Atrophy, Optic Atrophy Type 1, and Blepharitis.

Prior to joining VED in December, 2017, Dr. Hammer was with Baltimore Washington Eye Center. Dr. Hammer earned his medical degree from the University of Maryland, School of Medicine followed by an Internship at Eisenhower Army Medical Center in Augusta, Georgia. He then completed his training with a residency in Ophthalmology at the Walter Reed Army Medical Center which serves the greater Washington, DC Metro area. Dr. Hammer served as Chief of Ophthalmology at Ireland Community Hospital in Fort Knox, Kentucky. Dr. Hammer enjoys spending time with his family and is very involved with the community. His commitment and his passion for his work is demonstrated by the loyalty of his patients. Dr. Hammer is rated as an Experienced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Dry Eye Syndrome, Subconjunctival Hemorrhage, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Cataract Removal.

Dr. John Aucott is an associate professor of medicine at the Johns Hopkins University School of Medicine. An internist and Lyme disease expert in the Division of Rheumatology, he is the director of the Johns Hopkins Lyme Disease Clinical Research Center. With more than 15 years of research experience on the crippling effects of Lyme disease, he has published studies focusing on characteristics of early Lyme disease differences in males and females with an emphasis on prospects for prevention, diagnosis and treatment. Dr. Aucott received his medical degree from the Johns Hopkins University School of Medicine. He completed his residency in internal medicine at the University Hospitals of Cleveland. He is fellowship-trained in infectious disease and geographic medicine. Dr. Aucott and his colleagues were recognized by Johns Hopkins with a Discovery Fund Synergy Award in 2014. Dr. Aucott is rated as an Experienced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Lyme Disease, Synovitis, Reactive Arthritis, and Long Haul COVID.

Sharon D. Solomon, M.D., is the Katharine M. Graham Professor of Ophthalmology at the Wilmer Eye Institute. A retina specialist and ophthalmologist, Dr. Solomon's clinical expertise includes medical and surgical treatment of age-related macular degeneration, diabetic retinopathy, epiretinal membranes, macular holes, and retinal tears and detachment. Dr. Solomon has a large national and international referral practice at Wilmer. Dr. Solomon has served as principal investigator at Wilmer on a number of NIH-sponsored clinical trials. She has numerous publications from her clinical trials involvement. Dr. Solomon received her bachelor's degree in biochemistry from Harvard University and her medical degree from the University of California, San Francisco. After her internship at Stanford, she returned to UCSF for her residency in ophthalmology. Dr. Solomon completed her surgical retina fellowship at the Wilmer Eye Institute prior to joining the faculty. Dr. Solomon is a member of the prestigious Miller-Coulson Academy of Clinical Excellence at Johns Hopkins. Dr. Solomon is rated as an Experienced provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Gyrate Atrophy of the Choroid and Retina, and Vitrectomy.

Samuel C. Yiu, M.D., Ph.D., is an associate professor of ophthalmology at the Wilmer Eye Institute, specializing in cornea and external eye diseases, cataracts and refractive surgery (LASIK). In addition, he is a nationally and internationally recognized specialist in ocular surface diseases and ocular surface reconstruction surgery. Dr. Yiu received his M.Sc. (applied biometry) and Ph.D. (physiology and biophysics) from the University of Southern California. He then completed a post-doctoral fellowship in lacrimal physiology at the Schepens Eye Institute at Harvard Medical School and went on to earn his M.D. from the University of Alberta in Canada. Dr. Yiu completed an internship and his ophthalmology residency at Dalhousie University in Halifax, Nova Scotia and a fellowship in cornea, external disease and refractive surgery at the University of Southern California’s Doheny Eye Institute. After serving as the director of Doheny’s Ocular Surface Center and co-director of Doheny’s cornea division, Dr. Yiu joined the Wilmer faculty in 2011 and spent two years as the chief of the cornea division at King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Riyadh, Saudi Arabia, before returning to Baltimore in 2013. Dr. Yiu is rated as an Experienced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Cataract, Interstitial Keratitis, Dry Eye Syndrome, and Cloudy Cornea.

Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is rated as an Advanced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis.

Dr. Philip Seo is an Associate Professor in the Division of Rheumatology. A graduate of Harvard College and the College of Physicians and Surgeons at Columbia University, Dr. Seo completed his Internal Medicine training as a member of the Osler Medical Service at the Johns Hopkins Hospital. Since then, he has worked at Johns Hopkins in several capacities, including as a hospitalist at Johns Hopkins Bayview Medical Center, and as an Assistant Chief of Service of the Department of Medicine at the Johns Hopkins Hospital, before joining the Division of Rheumatology. Dr. Seo is the Director of the Johns Hopkins Vasculitis Center and Director of the Johns Hopkins Rheumatology Fellowship Program. His clinical interests lie in the assessment and treatment of patients with systemic vasculitis, in particular, the ANCA-associated vasculitides, which include granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. Dr. Seo is rated as an Advanced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy.

Louisa Ziglar is a Rheumatologist in Frederick, Maryland. Dr. Ziglar is rated as an Advanced provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Arthritis, Osteoporosis, Postmenopausal Osteoporosis, and Rheumatoid Arthritis (RA).

John Miller is a Rheumatologist in Baltimore, Maryland. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Lyme Disease, Rheumatoid Arthritis (RA), Diabetic Macular Edema (DME), Reactive Arthritis, and Vitrectomy.

Maria Chou is a Rheumatologist in Clinton, Maryland. Dr. Chou is rated as an Experienced provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Gout, Rheumatoid Arthritis (RA), Bursitis, and Tenosynovitis. Dr. Chou is currently accepting new patients.

Anshu Sinha is an Ophthalmologist in Columbia, Maryland. Dr. Sinha is rated as an Experienced provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Glaucoma, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Ocular Hypertension (OHT).

David Parver is an Ophthalmologist in Bethesda, Maryland. Dr. Parver is rated as an Experienced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Neuroretinitis, and Hyphema.

Seema Goyal is a Rheumatologist in North Bethesda, Maryland. Dr. Goyal is rated as an Experienced provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Raynaud Phenomenon, and Psoriatic Arthritis.

Yevgeniy Sheyn is a Rheumatologist in Clinton, Maryland. Dr. Sheyn is rated as an Experienced provider by MediFind in the treatment of Scleritis. His top areas of expertise are Fibromyalgia, Gout, Vitamin D Deficiency, and Tenosynovitis. Dr. Sheyn is currently accepting new patients.